Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Seres Therapeutics, Inc. | 10%+ Owner | Common Stock | 5.88M | $7.93M | $1.35 | Jul 5, 2022 | By Nutritional Health LTP Fund, L.P. |
Seres Therapeutics, Inc. | 10%+ Owner | Common Stock | 5.83M | $7.86M | $1.35 | Jul 5, 2022 | By Flagship Pioneering Fund VII, L.P. |
Seres Therapeutics, Inc. | 10%+ Owner | Common Stock | 4.43M | $5.99M | $1.35 | Jul 5, 2022 | By Flagship Ventures Fund IV, L.P. |
Seres Therapeutics, Inc. | 10%+ Owner | Common Stock | 2.96M | $4M | $1.35 | Jul 5, 2022 | By Flagship Pioneering Fund VI, L.P. |
Seres Therapeutics, Inc. | 10%+ Owner | Common Stock | 2.73M | $3.69M | $1.35 | Jul 5, 2022 | By Flagship VentureLabs IV LLC |
Seres Therapeutics, Inc. | 10%+ Owner | Common Stock | 1.28M | $1.73M | $1.35 | Jul 5, 2022 | By Flagship Ventures Fund IV-Rx, L.P. |
Seres Therapeutics, Inc. | 10%+ Owner | Common Stock | 376K | $508K | $1.35 | Jul 5, 2022 | By Noubar B. Afeyan, Ph.D. |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MCRB | Seres Therapeutics, Inc. | Jul 5, 2022 | 2 | $27.5M | 4 | Jul 7, 2022 | 10%+ Owner |
MCRB | Seres Therapeutics, Inc. | May 17, 2021 | 1 | $0 | 4 | May 19, 2021 | 10%+ Owner |